About Genesys Biologics Private Limited
Data last updated:
Genesys Biologics Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 18 November 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2014PTC096432. Its GSTIN is 36AAFCG8257M1Z0 (Telangana).
The company has an authorised share capital of ₹3.5 Cr and a paid-up capital of ₹2.33 Cr. It is led by directors including Tulasiramu Chatadi (Whole-Time Director) and Venkata Krishna Rao Dasari (Whole-Time Director).
Its last annual general meeting (AGM) was held on 28 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 6 – 3 – 248/1/1/A 4th Floor Bhaskar Plaza Road No1 Banjara Hills, Hyderabad, Telangana, India – 500034.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.08 Cr, a growth of 87% compared to the previous year. For the same year it recorded a net loss of ₹70.81 Cr and EBITDA of -₹50.24 Cr. Revenue has grown at a compounded annual rate (CAGR) of 325% over three years and 98% over five years.
The company has about 259 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: GeneSys Biologics. As per MCA filings, the company has open charges of ₹58.5 Cr and satisfied charges of ₹61.28 Cr on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending. The company has 28 deals on record (21 rights issues, 4 funding rounds, 3 secondary share transfers), with disclosed funding of ₹125.7 Cr; the latest was in November 2021.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genesysbiologics.com.
Company details
Contact details
Genesys Biologics Private Limited's registered office is in Hyderabad, Telangana. Its website is genesysbiologics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address6 – 3 – 248/1/1/A 4th Floor Bhaskar Plaza Road No1 Banjara Hills, Hyderabad, Telangana, India – 500034
- IndustryLife Sciences, Biotechnology
To see the full contact details of Genesys Biologics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Genesys Biologics operates one associated brand: GeneSys Biologics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| R&D company focused on manufacturing of insulin biosimilars for multiple therapeutic areas | genesysbiologics.com |
Business activity
The main business activity of Genesys Biologics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Genesys Biologics Private Limited, buy the company report.
Financials of Genesys Biologics Private Limited
FY 2024 filings availableGenesys Biologics Private Limited reported revenue of ₹6.08 Cr (up 87% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 98% over five years, including 87% growth in the latest year. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹50.24 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹70.81 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Genesys Biologics Private Limited, buy the company report.
Board of directors of Genesys Biologics Private Limited
Genesys Biologics has 5 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kondrella Roopesh Also directs: Sagarsoft (India) Limited | Director | 06 Feb 2015 | 11 Years 9 Months | Current |
| Tulasiramu Chatadi Also directs: Rygen Biopharma Private Limited | Whole-Time Director | 20 Aug 2015 | 11 Years 2 Months | Current |
| Venkata Krishna Rao Dasari Also directs: Rygen Biopharma Private Limited | Whole-Time Director | 20 Aug 2015 | 11 Years 2 Months | Current |
| Vamshider Joganpally Rao | Director | 18 Nov 2014 | 11 Years 11 Months | Current |
| Yelma Venkat Reddy | Director | 05 Feb 2015 | 11 Years 9 Months | Current |
Auditor
Genesys Biologics Private Limited is audited by ANANT RAO & MALLIK for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANANT RAO & MALLIK | FY 2023 | 006266S |
Shareholding
The shareholding of Genesys Biologics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Genesys Biologics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Jul 2017 | 100114599 | State Bank of India | ₹58.5 Cr | Open | |
| 03 Aug 2018 | 100200402 | State Bank of India | ₹11 Cr | Satisfied | |
| 07 Sep 2017 | 100203811 | Others | ₹22.5 Lakh | Satisfied | |
| 02 Apr 2017 | 100107598 | State Bank of India | ₹36 Cr | Satisfied | |
| 29 Oct 2016 | 100203812 | Others | ₹55 Lakh | Satisfied |
To see the full charge records of Genesys Biologics Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Genesys Biologics Private Limited has 28 deals on record (21 rights issues, 4 funding rounds, 3 secondary share transfers), with disclosed funding of ₹125.7 Cr; the latest was in November 2021.
Deals on record (5 of 28)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2021 | Funding round | ₹85 Cr | Investors: Relentless Bio Sciences LLP |
| Jul 2017 | Rights issue | ₹82 Lakh | Investors: Amicus Formulations India Private Limited |
| Jun 2017 | Rights issue | ₹2.97 Cr | Investors: Amicus Formulations India Private Limited |
| Jun 2017 | Rights issue | ₹1.81 Cr | Investors: Amicus Formulations India Private Limited |
| May 2017 | Rights issue | ₹3.56 Cr | Investors: Amicus Formulations India Private Limited |
To see the full deal history of Genesys Biologics Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Genesys Biologics Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
| NCLT | 1 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Hyderabad | Insolvency matter | Filed against the company by Zydus Healthcare Limited | Disposed |
| District court, Hyderabad CCC, Telangana | Civil suit | Filed against the company by an individual | Pending |
To see the full case history of Genesys Biologics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Genesys Biologics Private Limited was last rated by Care on 10 Dec 2025.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 10 Dec 2025 |
To see the full credit ratings and regulatory alerts of Genesys Biologics Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Genesys Biologics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Genesys Biologics has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
Employees & EPFO
Genesys Biologics Private Limited has a workforce of 259 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Genesys Biologics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCG8257M1Z0 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Genesys Biologics Private Limited, buy the company report.
Recent activity
Genesys Biologics Private Limited has 12 board changes on record since 2014: 5 appointments and 7 cessations. The latest: Krishna Yeachuri ceased to be Director on 27 Oct 2022.
15 earlier events are in the company report.
Frequently asked questions
Genesys Biologics is an active private limited company based in Hyderabad, Telangana, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 18 November 2014 (12+ years old) and is registered under CIN U24232TG2014PTC096432.
Genesys Biologics has 5 current directors:
- Tulasiramu Chatadi - Whole-Time Director
- Venkata Krishna Rao Dasari - Whole-Time Director
- Kondrella Roopesh - Director
- Vamshider Joganpally Rao - Director
- Yelma Venkat Reddy - Director
The latest financial statements of Genesys Biologics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 28 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Genesys Biologics is 36AAFCG8257M1Z0, registered in Telangana.
The CIN (Corporate Identification Number) of Genesys Biologics is U24232TG2014PTC096432. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genesys Biologics has 2 court cases on record: 2 filed against it. 1 is pending. Most are in the district courts.
Genesys Biologics was incorporated on 18 November 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
Genesys Biologics has 28 deals on record (21 rights issues, 4 funding rounds, 3 secondary share transfers), with disclosed funding of ₹125.7 Cr; the latest was in November 2021.
Krishna Yeachuri ceased to be Director on 27 Oct 2022. Upendar Mekala Reddy ceased to be Additional Director on 27 Oct 2022. Rajender Juvvadi Rao ceased to be Director on 31 Jul 2020. Genesys Biologics has 12 board changes on record in total.
Genesys Biologics can be reached through the website genesysbiologics.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
